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'instant coffee', made from 100% coffee, contains 4,38%.
Details of the history, mode of manufacture and
chemical compositions of tea, coffee and cocoa are given
bv a number of authors, for example Sinclair and
Hollingsworth.' An account of the active principles in
these and other beverages is also given by Sapeika.'
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Effect of Ascorbic Acid on Lipoprotein
Lipase Activity
J. P. KOTZt, M. J. A. MATTHEWS, W. A. DE KLERK
SUMMARY
Baboons kept on hypovitaminotic C diets, but without
clinical signs of scurvy, had significantly higher heart
muscle lipoprotein lipase activity than baboons on
vitamin C 34 mg/kg body mass/day. When the serum
vitamin C levels were above 0,35 mg/100 ml the heart
muscle lipoprotein lipase was repressed. Serum vitamin C
levels below 0,35 mg/100 ml stimulated lipoprotein lipase
to between 2 and 3 times the repressed value.
Heart muscle lipoprotein lipase from baboons receiving
dietary vitamin C was inhibited by 0,34 mM vitamin C
in vitro, whereas heart muscle lipoprotein lipase from
baboons on scorbutogenic diets were stimulated by addi-
tion of vitamin C in vitro.
S. Afr. Med. l., 48, 511 (1974).
The uptake of triglyceride fatty acids from the plasma by
extrahepatic tissues is facilitated through hydrolysis of the
triglycerides by the enzyme, clearing factor lipase or lipo-
protein lipase. Various authors have given evidence that
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the enzyme acts at the surface of the capillary endothelial
cells where the triglycerides, carried in the plasma very-
low-density lipoproteins or chylomicrons, are sequestered. I,'
Robinson3,< also maintained that lipoprotein lipase plays
a directive role in determining the pattern of triglyceride
fatty acid uptake by extrahepatic tissues.
Recently, various workers have presented data indica-
ting that the adipose tissue and heart muscle contain lipo-
protein lipases having different characteristics. l .'.'
The activities of the enzyme in specific tissues have
been shown to change in particular physiological situations
and such changes can be correlated with alterations in the
uptake of triglyceride fatty acids by these tissues. In adipose
tissue, for example, the activity of the enzyme is high in
the fed state, when triglyceride fatty acids are taken up,
and low in the fasted state, when uptake of triglyceride
fatty acids is low. In the heart muscle, on the other hand.
the activity of lipoprotein lipase is low during feeding and
is elevated during fasting, when the flow of triglyceride
fatty acids is from the depot fat region towards utilisation
of the heart muscle.
Ascorbic acid has been implicated in the control of
serum cholesterol levels by a number of investigations"o'l>
although Anderson et al." have questioned the serum
lipid-lowering effect of ascorbic acid.
Sokoloff et al." also discussed the decrease of serum
lipoprotein lipase activity during severe atherosclerosis, and
serum lipid values and the improvement of lesions during
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TABLE I. RELATIONSHIP BETWEEN SERUM ASCORBIC AClfJ
LEVELS AND BABOON HEART MUSCLE LIPOPROTEIN
LIPASE
National Park." The level of ascorbic acid of 34 mg/kg
day is also much higher than the requirements of 2 mg/kg
day'" and 7,5 mg/kg/day reported by Shaw et al.'" fa'
primates.
The heart lipoprotein lipase activity decreased by a
factor of 7,2, from a high value of 549 to a low value of
76 (Table I).
Examination of the data indicated that apparently a
minimal serum ascorbic acid level of about 0,35 mg/ dl
existed, below which the lipoprotein lipase actively in-
creased steeply (Fig. 1). At serum ascorbic acid values
above 0,35 mg/dl, however, heart lipoprotein lipase ap-
peared to be repressed. This is of interest, because Taylor"
reported that petechial haemorrhages around hair follicles
appeared at serum ascorbic acid levels of about 0,2 mg/dl.
which corresponds to 15 fLg ascorbic acid per 10' leuco-
cytes.
When heart muscle homogenates of baboons with dif-
ferent serum ascorbic acid levels were incubated in vitro
with 0,34 mM ascorbic acid during the assay, it was found
that at low serum ascorbic acid levels the addition of
ascorbic acid stimulated the enzyme activity (103,7%), and
at high serum ascorbic acid levels inhibited it (61,3%)
(Table II).
The acetone powder of baboon heart muscle was de-
pleted of ascorbic acid. Addition of ascorbic acid to the
assay medium also effected a stimulation of the lipoprotein
lipase activity to 122,2 % of the original value. Although
stimulation of lipoprotein lipase by ascorbic acid occurred,
the effect was always small. .
Heart muscle vitamin C levels paralleled those of the
serum.
Andrews et al. H found that in the elderly human, vitamin
C deficiencies often occurred and that higher intakes than
the recommended 30 mg/day were necessary to bring
leucocyte values back to those of young people. Similarly,
postheparin lipase activity was often found to be deficient
in old age." We therefore set out to determine the re-
lationship between serum ascorbic acid levels and heart
lipoprotein lipase. A preliminary report of our findings
has been published."
MATERIALS AND METHODS
Baboons were kept on diets as described by Kotze and
Kempff," and De Klerk et al. lS
The diets were supplemented with various quantities of
ascorbic acid to obtain different serum levels. Blood
samples were obtained by venepuncture under phencycli-
dine hydrochloride anaesthesia (1 mg/kg body mass)
(Sernylan; Parke-Davis). Blood samples were allowed to
clot and the serum was separated by centrifugation. Serum
ascorbic acid was determined according to the method of
Roe and Kuether19 as modified by Schaffert and Kingsley."
Heart muscle samples were obtained after phenobarbi-
tone euthanasia and immediate autopsy. The apex of the
heart muscle was excised and rinsed in Krebs-Ringer bi-
carbonate buffer, blotted on filter paper, weighed, and
three times its mass of Krebs-Ringer bicarbonate buffer
added. It was then minced with scissors and homogenised
for 1 minute with Ultra Turrax homogeniser in the cold.
Heparin was added to the homogenate to yield a final
concentration of 250 units/ml, and this was subsequently
incubated for 30 minutes at 25°C under a constant flow
of a gas mixture containing 95% 0, and 5% CO,.
Lipoprotein lipase was determined according to the
method of Huttunen and Steinberg,Ol with the modifica-
tion that the liberated free fatty acids were determined
according to N ovak 's" method. Dry mass of the homo-
genate was determined by mass difference after drying an
aliquot for 24 hours at 105°C.
Lipoprotein lipase results are always the average of at
least 6 different determinations. The effect of ascorbic acid
on lipoprotein lipase activity was done by addition of
ascorbic acid to the assay medium to a final concentra-
tion of 0,34 mM (6 mg/lOO ml).
Acetone extracts of heart muscle homogenates were
prepared as described by Garfinkel and Schotz."
RESULTS
Determinations of serum ascorbic acid levels and the lipo-
protein lipase activities of baboon heart muscle homo-
genates indicate a definite inverse relationship between
these entities. The serum ascorbic acid level varied 12,7-
fold from a low value of 0,11 mg/dl to 1,41 mg/dl. It is of
interest because after 7 young baboons had been kept on
ascorbic acid 34 mg/kg body mass/day for at least 3
months, 1,41 mg / dl was the highest serum level obtained,
which was still lower than the average value of 1,56 mg/dl
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Fig. 1. The relationship between serum ascorbic acid levels and baboon heart
muscie lipoprotein lipase.
TABLE 11. EFFECT OF ADDED ASCORBIC ACID TO
IN VITRO LIPOPROTEIN LIPASE ACTIVITIES OF BABOON
HEART MUSCLE HOMOGENATES (ASCORBIC ACID IN
ASSAY WAS 0,34 mM)
Lipoprotein Iif=ase
activity as % Heart
(control 100%) Serum muscle
AA level AA level
- Asc. + Asc. (mg/100 9 (mg/100 9
acid acid wet mass) wet mass
100 35,0 0,60 9,1
100 56,8 1,27 14,8
100 84,2 0,76 9,3
100 39,5 0,41 2,2
100 91,0 1,29 15,6
Average 61,3 0,87 10,2
SD -+-25,46 -+-0,40 -+- 5,39
I
100 105,6 0,31 5,2
100 106,0 0,29 2,7
100 107,0 0,30 5,7
100 103,7 0,09 1,4
100 107,0 0,22 4,5
100 93,1 0,18 4,6
Average 103,7 0,27 4,0




There is experimental evidence that during fasting lipo-
protein lipase from heart and skeletal muscle increases:·7 ,.
Borenstajn et al.' found that insulin could not preyent
the increase of heart lipoprotein lipase elicited by starva-
tion. It thus appears that there are other factors besides
insulin that control heart lipoprotein lipase activity.
It is not clear how the feeding of ascorbic acid can
have a repressive effect on lipoprotein lipase synthesis;
because such a mechanism, if any, is unknown.
According to recent reports the lipoprotein lipase from
heart muscle is not a single entity. Schotz and Garfinkel'
described two molecular species of rat heart lipoprotein
lipase, one, LPL.. was stimulated by heparin, whereas the
other, LPLb , was inhibited by heparin, and concluded that
both species were increased during fasting.
Sokoloff et al." suggested that ascorbic acid at doses of
150 mg / kg body mass / day could counteract the decrease
of lipoprotein lipase of rabbit and rat serums caused by
cholesterol feeding. This finding is, however, not directly
relevant, since these animals synthesise their daily ascorbic
acid requirements from glucose, whereas primates, like the
baboon and man, do not synthesise their own ascorbic
acid but must receive it from external sources.
The fact that adipose tissue and heart muscle lipoprotein
lipase react differently to physiological stimuli like feeding
and fasting, suggests that whereas an ascorbic acid de-
ficiency caused a rise in heart lipoprotein lipase activity,
a concomitant decrease of adipose tissue lipoprotein lipase
should occur. However, high serum ascorbic acid levels
should increase adipose tissue lipoprotein lipase and, there-
fore, tend to lower serum triglyceride fatty acid levels.
Sokoloff et al." maintained that large doses of ascorbic
acid (2 - 3 g/ day) and restriction of lipid intake lowered
the triglyceride and cholesterol levels of hyperlipidaemic
patients.
It is also of interest that a serum ascorbic acid level of
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about 0,35 mg/ dl was found to be sufficient to result in a
low heart muscle lipoprotein lipase activity and probably
to ensure an efficient level of adipose tissue lipoprotein
lipase activity. This serum ascorbic acid level is just above
the 0,2 mg/ dl serum ascorbic acid level reported to cause
petechial haemorrhage of hair follicles."
In vitro incubation of heart lipoprotein lipase with addi-
tional 0,34 mM ascorbic acid caused a stimulation of the
enzyme activity if the homogenate originated from a baboon
with a low serum ascorbic acid level, and inhibited the
lipoprotein lipase when the homogenate was from a
baboon with a high serum ascorbic acid level. This finding
suggests that we may be dealing with three phenomena.
Firstly, the feeding of ascorbic acid controls the level of
lipoprotein lipase synthesis, or only one of the LPL. or
LPLh species as reported by Garfinkel and Schotz.,"J Se-
condly, that in addition to this effect, which probably in-
volves protein synthesis, we have a more direct effect of
allosteric enzyme activity modulation by different ascorbic
acid concentrations in vitro. A third possibility exists in
that the two species LPLa and LPL;) react differently to
ascorbic acid, as was reported for the reaction with
heparin.'
It would seem, therefore, that ascorbic acid definitely
exerts a controlling effect on lipoprotein lipase activity
and consequently on serum lipid levels.
At present our knowledge about the intricacies of the
process is still lacking and further investigation is war-
ranted.
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